MONDAY, Oct. 9, 2023 (HealthDay News) — Researchers have developed an antibody that can reduce Alzheimer’s-like brain damage in lab mice — inspired by the case of one woman with remarkable resistance to the disease. The work, by researchers at Mass General Brigham, Harvard Medical School in Boston, and elsewhere,Continue Reading

MONDAY, Sept. 18, 2023 (HealthDay News) — Perhaps succumbing to fraudsters or facing mounting bills, older Americans begin losing wealth in the years preceding a definitive dementia diagnosis, new research shows. For example, the median household net worth of the seniors in the study dropped by more than half inContinue Reading

THURSDAY, Sept. 14, 2023 (HealthDay News) — Many Medicare patients can’t get help close to home for brain and nervous system issues. Nearly 1 in 5 Medicare recipients in the United States live at least 50 miles from their neurologist. “Our study found a substantial travel burden exists for someContinue Reading

FRIDAY, Sept. 8, 2023 (HealthDay News) — Therapies based on a hormone people make while exercising may be the next frontier in treating Alzheimer’s disease, according to a new study. Researchers have found that the exercise-induced hormone irisin may reduce both the plaque and the tau tangles characteristic of theContinue Reading

FRIDAY, Aug. 25, 2023 (HealthDay News) — Older people who take adult education classes may lower their risk for dementia, including Alzheimer’s disease, Japanese research suggests. Middle-aged folks and older people in adult education classes had a 19% lower risk of developing dementia within five years, the researchers found. “WeContinue Reading

MONDAY, Aug. 21, 2023 (HealthDay News) — Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer’s disease, new research reveals. Prior vaccination with the shingles vaccine, pneumococcus vaccine or the tetanus and diphtheria shot, with or without an added pertussis vaccine, are associated withContinue Reading

THURSDAY, Aug. 17, 2023 (HealthDay News) — Two recently approved treatments offer newfound hope for patients in the early stages of Alzheimer’s disease, but most people who could benefit will likely be deemed ineligible, a new study finds. Alzheimer’s affects about 6.7 million Americans age 65 and older. But onlyContinue Reading